Publications by authors named "Vivek Tomar"

Claim this Profile
N
Non-DRE Voided Urine Test to Diagnose Prostate Cancer: Updated Results.
Patrick T Gomella, Joon Yau Leong, Leonard G Gomella, Vivek S Tomar, Hector Teran

Diagnostics (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia.
Mathew Thakur, Vivek S Tomar, Emma Dale, Leonard G Gomella, Charalambos Solomides

BJUI Compass· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes.
Zhen Lu, Noreen McBrearty, Jinyun Chen, Vivek S Tomar, Hongru Zhang

Cell Metab· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A burden shared: the financial, psychological, and health-related consequences borne by family members and caregivers of people with cancer in India.
Sruthi Ranganathan, Vivek Tomar, Fumiko Chino, Bhav Jain, Tej A Patel

Support Care Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment.
Hongru Zhang, Vivek S Tomar, Jinyang Li, Raghavendra Basavaraja, Fangxue Yan

Cancer Immunol Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor factors stimulate lysosomal degradation of tumor antigens and undermine their cross-presentation in lung cancer.
Zhen Lu, Jinyun Chen, Pengfei Yu, Matthew J Atherton, Jun Gui, Vivek S Tomar

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATF3 and CH25H regulate effector trogocytosis and anti-tumor activities of endogenous and immunotherapeutic cytotoxic T lymphocytes.
Zhen Lu, Noreen McBrearty, Jinyun Chen, Vivek S Tomar, Hongru Zhang

Cell Metab· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiresolution-Based Singular Value Decomposition Approach for Breast Cancer Image Classification.
Suman Mann, Amit Kumar Bindal, Archana Balyan, Vijay Shukla, Zatin Gupta, Vivek Tomar

Biomed Res Int· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting PARP11 to avert immunosuppression and improve CAR T therapy in solid tumors.
Hongru Zhang, Pengfei Yu, Vivek S Tomar, Xiangjie Chen, Matthew J Atherton

Nat Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Priorities for cancer research in low- and middle-income countries: a global perspective.
C S Pramesh, Rajendra A Badwe, Nirmala Bhoo-Pathy, Christopher M Booth, Girish Chinnaswamy, Vivek Tomar

Nat Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
Vivek Singh Tomar, Vikas Patil, Kumaravel Somasundaram

Cell Biol Toxicol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis.
Siddharth Singh, Manoj Kumar, Sanjeev Kumar, Shrinka Sen, Pawan Upadhyay, Vivek Singh Tomar

J Biol Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1), a pseudo phosphatase, promotes oncogenesis in glioma.
Vivek Singh Tomar, Tapan Kumar Baral, Krishnaveni Nagavelu, Kumaravel Somasundaram

Biochem Biophys Res Commun· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer.
Shabir Zargar, Vivek Tomar, Vidyarani Shyamsundar, Ramshankar Vijayalakshmi, Kumaravel Somasundaram

Mol Cell Biol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current-induced stabilization of surface morphology in stressed solids.
Vivek Tomar, M Rauf Gungor, Dimitrios Maroudas

Phys Rev Lett· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis